Cancer Therapy News and Research

RSS

UC Davis researchers link increased body fat and lethal drug reactions in mice

Immunotherapy that can be effective against tumors in young, thin mice can be lethal to obese ones, a new study by UC Davis researchers has found. The findings, published online today in The Journal of Experimental Medicine, suggest a possible link between body fat and the risk of toxicity from some types of immunotherapy.

3 Nov 2014

Epicure project: an interview with Frédéric Cren

Epicure is a project led by Inventiva and Institut Curie that aims to deliver pre-clinical candidates on two novel epigenetic targets that have been selected due to their potential to activate immune responses against cancer cells. In addition one of these two targets has potential in respiratory indications such as asthma or COPD.

3 Nov 2014

Novel therapeutic approaches to improve thyroid cancer outcomes

Novel therapeutic approaches to improve outcomes in thyroid cancer, for example using targeted delivery of cytotoxic drugs to tumor cells, will be among the topics featured in oral and poster presentations delivered at the 84th Annual Meeting of the American Thyroid Association, October 29-November 2, 2014, in Coronado, California.

30 Oct 2014

Major research project aims to reduce chances of hair loss after chemotherapy treatment

Cancer suffers who lose their hair as a consequence of chemotherapy will benefit from a major research project that will improve the scalp cooling technology that prevents hair loss.

From Paxman 30 Oct 2014

Game theory and the cancer ecosystem: an interview with Professor Pienta, Johns Hopkins

The classic description of game theory was described by the prisoner's dilemma, which is a situation in which two players have two options where the outcome depends on the simultaneous choice made by the other.

29 Oct 2014

Generic aromatase inhibitors increase breast cancer treatment adherence by 50%

Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.

28 Oct 2014

New research suggests that TEM5 protein may be a good target for cancer therapy

Do blood vessels that feed tumors differ from other blood vessels? Fourteen years ago, experiments designed to answer that question led to the discovery of several genes that are more active in tumor-associated blood vessels than in normal blood vessels. New research now reveals the normal function of one of those genes and suggests it could be a good target for anticancer drug therapy.

28 Oct 2014

GenomOncology's GO Clinical Workbench selected by UH to launch clinical cancer product

GenomOncology today announced that University Hospitals Case Medical Center and UH Seidman Cancer Center (Cleveland, Ohio) have selected the company's GO Clinical Workbench to launch a clinical cancer product. UH will leverage the GO Clinical Workbench for workflow management from raw sequencing data through delivery of an actionable clinical report for oncologists.

27 Oct 2014

Concord Medical gets approval to establish Datong Meizhong Jiahe Cancer Center

Concord Medical Services Holdings Limited, an operator of specialty cancer hospitals and the largest network of radiotherapy and diagnostic imaging centers in China, today announced that the Company has received relevant government approvals to establish a free-standing radiotherapy cancer center, Datong Meizhong Jiahe Cancer Center ("Datong Center") in Datong City, Shanxi Province.

27 Oct 2014

Financial burden higher in patients treated for colorectal cancer

Nearly two-thirds of patients treated for colorectal cancer reported some measure of financial burden due to their treatment, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

27 Oct 2014

The PROBEAT-RT Proton Beam Therapy System incorporating real-time tumor-tracking is approved in Japan

Hokkaido University and Hitachi, Ltd. have announced that the approval under Japan’s Pharmaceutical Affairs Law has been granted to Hitachi for the manufacture and sales of the PROBEAT-RT, a proton beam therapy treatment system combining spot scanning irradiation and Real-time Tumor-tracking Radiation Therapy.

23 Oct 2014

GE Healthcare’s advances in imaging quantitation may help clinicians diagnose disease earlier

GE Healthcare shares a suite of advances in imaging quantitation that may help clinicians diagnose disease earlier, deliver more personalised treatment and speed up care at the 27th annual meeting of the European Association of Nuclear Medicine (EANM), 18-22 October, in Gothenburg.

21 Oct 2014

Van Andel Research Institute commits $7.5M to support epigenetic therapy in cancer treatment

The work of one of the Stand Up To Cancer (SU2C) inaugural Dream Teams, launched in 2009 to focus on epigenetic therapy in cancer treatment, will continue with the commitment of $7.5 million from Van Andel Research Institute (VARI).

20 Oct 2014

NICO, Synaptive Medical join forces to integrate innovative technologies for brain surgery

Indianapolis interventional medical device maker NICO Corporation and Toronto-based 3D visualization leader Synaptive Medical announced today at the Congress of Neurological Surgeons Annual Meeting that they have joined forces to integrate their innovative technologies for brain surgery.

20 Oct 2014

Genetic changes in blood cells of older people linked to lymphoma, leukemia

At least 2 percent of people over age 40 and 5 percent of people over 70 have mutations linked to leukemia and lymphoma in their blood cells, according to new research at Washington University School of Medicine in St. Louis.

20 Oct 2014

Anti-cancer nanomedicines with smaller sizes exhibit enhanced performance in vivo, show studies

Nanomedicines consisting of nanoparticles for targeted drug delivery to specific tissues and cells offer new solutions for cancer diagnosis and therapy.

17 Oct 2014

Statistical analysis shows stage of breast cancer predicts treatment choice

Why did 43 percent of South Dakota women diagnosed with early-stage breast cancer surveyed choose mastectomy rather than lumpectomy?

17 Oct 2014

New automaton model simulates various scenarios of tumor growth

Cancer constantly wages war on the human body. Battles are won, lost or sometimes end in a stalemate. In pancreatic cancer, this stalemate—known as tumor dormancy—can last up to 25 years before becoming aggressively malignant, a phenomena that is poorly understood.

17 Oct 2014

California agency issues 'report cards' on insurers, medical groups

The California Office of the Patient Advocate Wednesday released the report cards, which are based on 2013 claims data and patient surveys, a month ahead of Covered California's 2015 open enrollment period.

16 Oct 2014

Study: Nursing home care quality not associated with risk of hospital readmission or death

Nursing home care quality does not impact the likelihood of patients being readmitted to the hospital or dying within 30 days of discharge from hospital to nursing home, according to a new analysis of Medicare data and nursing home performance measures by Penn Medicine researchers.

16 Oct 2014

Cancer Therapy News and Research

UC Davis researchers link increased body fat and lethal drug reactions in mice

Epicure project: an interview with Frédéric Cren

Novel therapeutic approaches to improve thyroid cancer outcomes

Major research project aims to reduce chances of hair loss after chemotherapy treatment

Game theory and the cancer ecosystem: an interview with Professor Pienta, Johns Hopkins

Generic aromatase inhibitors increase breast cancer treatment adherence by 50%

New research suggests that TEM5 protein may be a good target for cancer therapy

GenomOncology's GO Clinical Workbench selected by UH to launch clinical cancer product

Concord Medical gets approval to establish Datong Meizhong Jiahe Cancer Center

Financial burden higher in patients treated for colorectal cancer

The PROBEAT-RT Proton Beam Therapy System incorporating real-time tumor-tracking is approved in Japan

GE Healthcare’s advances in imaging quantitation may help clinicians diagnose disease earlier

Van Andel Research Institute commits $7.5M to support epigenetic therapy in cancer treatment

NICO, Synaptive Medical join forces to integrate innovative technologies for brain surgery

Genetic changes in blood cells of older people linked to lymphoma, leukemia

Anti-cancer nanomedicines with smaller sizes exhibit enhanced performance in vivo, show studies

Statistical analysis shows stage of breast cancer predicts treatment choice

New automaton model simulates various scenarios of tumor growth

California agency issues 'report cards' on insurers, medical groups

Study: Nursing home care quality not associated with risk of hospital readmission or death

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News